ABL1 and acute lymphoblastic leukemia: Of note, SUP and REH B-ALL cell lines possess different disease-initiating genetic aberrations (expressing BCR-ABL1 and ETV6-RUNX1, respectively), indicating that genetic features may influence the disease microenvironment and thus, the efficacy of microenvironment-targeted therapies.